IFNB1 and leprosy: If this is the case, then our study may have implications in the treatment of leprosy and other mycobacterial diseases since the induction of IFN-β responses in lepromatous leprosy may be blocked by a treatment strategy that directly inhibits TLR4-TRIF signaling.